Patient presents with signs and symptoms suggestive of Mixed Connective Tissue Disease (MCTD).  The patient reports experiencing Raynaud's phenomenon, characterized by episodic digital ischemia with color changes in the fingers and toes, triggered by cold exposure or stress.  Swelling of the hands and fingers, consistent with hand edema, is also noted.  The patient complains of arthralgia, specifically joint pain affecting multiple joints, with associated morning stiffness.  Fatigue and generalized weakness are prominent symptoms impacting daily activities.  Dysphagia, difficulty swallowing, has been reported intermittently.  Physical examination reveals swollen hands and limited range of motion in affected joints.  Laboratory findings indicate positive antinuclear antibodies (ANA) with high titers of anti-U1 ribonucleoprotein (anti-U1 RNP) antibodies.  The patient's presentation fulfills the diagnostic criteria for MCTD, exhibiting features of systemic lupus erythematosus (SLE), systemic sclerosis (scleroderma), and polymyositis.  Differential diagnoses considered include undifferentiated connective tissue disease (UCTD), overlap syndrome, and other rheumatic diseases.  A treatment plan is initiated, focusing on symptom management and includes nonsteroidal anti-inflammatory drugs (NSAIDs) for arthralgia and pain control, corticosteroids to address inflammation and disease activity, and immunosuppressants if indicated for more severe manifestations.  Patient education regarding MCTD prognosis, potential complications such as pulmonary hypertension and renal involvement, and the importance of regular follow-up care are provided.  Referral to rheumatology for ongoing specialist management is recommended.  ICD-10 code M35.1 (Mixed connective tissue disease) is documented for medical billing and coding purposes.